全文获取类型
收费全文 | 858篇 |
免费 | 150篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 2篇 |
妇产科学 | 2篇 |
基础医学 | 26篇 |
口腔科学 | 9篇 |
临床医学 | 60篇 |
内科学 | 374篇 |
神经病学 | 27篇 |
特种医学 | 15篇 |
外科学 | 112篇 |
综合类 | 32篇 |
预防医学 | 284篇 |
药学 | 14篇 |
中国医学 | 9篇 |
肿瘤学 | 47篇 |
出版年
2024年 | 13篇 |
2023年 | 84篇 |
2022年 | 162篇 |
2021年 | 211篇 |
2020年 | 103篇 |
2019年 | 91篇 |
2018年 | 56篇 |
2017年 | 48篇 |
2016年 | 34篇 |
2015年 | 30篇 |
2014年 | 37篇 |
2013年 | 43篇 |
2012年 | 13篇 |
2011年 | 19篇 |
2010年 | 12篇 |
2009年 | 6篇 |
2008年 | 8篇 |
2007年 | 7篇 |
2006年 | 7篇 |
2005年 | 6篇 |
2004年 | 6篇 |
2003年 | 7篇 |
2002年 | 7篇 |
2001年 | 4篇 |
1997年 | 1篇 |
排序方式: 共有1015条查询结果,搜索用时 15 毫秒
61.
Jared M. Weiss MD Nathan Pennell MD PhD Allison M. Deal MS Daniel Morgensztern MD Daniel S. Bradford MD Jeffrey Crane MD Howard Jack West MD Carrie Lee MD Chad Pecot MD James P. Stevenson MD William Irvin MD Mark Socinski MD Tom Stinchcombe MD Liza C. Villaruz MD Hyman B. Muss MD 《Cancer》2020,126(5):1060-1067
62.
Baseline Sarcopenia is Associated with Lack of Response to Therapy,Liver Decompensation and High Mortality in Hepatocellular Carcinoma Patients 下载免费PDF全文
Hanaa BadranMaha Mohammad ElsabaawyAmr RagabRasha Abdelhafiz AlyAyman AlsebaeyAliaa Sabry 《Asian Pacific journal of cancer prevention》2020,21(11):3285-3290
Objective: hepatocellular carcinoma (HCC) is a dreadful complication of liver cirrhosis. Aim was to study the effect of sarcopenia on the survival in patients with HCC. Methods: we included 262 patients and were followed up for 12 months. Sarcopenia was calculated by skeletal muscle index (SMI). Sarcopenia was defined by SMI ≤39 cm2/m2 for women and ≤50 cm2/m2 for men. Results: patients with sarcopenia (n= 113, 43.1%) were older, mainly males, Child-Pugh class B and smokers. Patients with sarcopenia had lower survival than those without (10.09 vs. 11.72 months). Survival was also lower in Barcelona clinic liver cancer stage C than B and A (9.02 vs. 11.21 vs. 11.89 months). Age and sarcopenia were hazardous of mortality (p <0.05). There was statistically significant difference of serial SMI in patients without baseline sarcopenia unlike patients with baseline sarcopenia. On follow up patients with sarcopenia had higher incidence of ascites (45% vs. 20.4%), spontaneous bacterial peritonitis (21.7% vs. 11.6%), hepatic encephalopathy (28% vs. 11.5%) and bleeding (22.9% vs. 12.7%). Totally patients with sarcopenia had higher incidence of progressive HCC (39% vs. 25.5%). Conclusion: Sarcopenia is associated with lack of response to therapy, liver decompensation and higher mortality in hepatocellular carcinoma patients. 相似文献
63.
肌少症是与增龄相关的肌肉质量减少和功能减退,其增加了摔倒、骨折、死亡及住院等风险,严重威胁老年人健康。构建动物模型是开展肌少症发病机制、临床干预及治疗方案设计研究的基础。由于肌少症表型的复杂性,使得选择合适的造模方法、构建恰当的动物模型至关重要。本文综述了近年来肌少症动物模型造模方法的相关进展,为开展肌少症发病机制、预防、治疗等相关研究提供参考。 相似文献
64.
Malnutrition has a multifactorial origin and can be caused by cancer. This study determined the consensus of a panel of experts on the nutritional approach for cancer patients in Spain using a multidisciplinary approach. Using the Delphi methodology, a 74-question questionnaire was prepared and sent to 46 experts. The areas of knowledge addressed were the nutritional status of the cancer patient, nutritional screening, nutritional therapy, patient referral, and multidisciplinary care. A total of 91.7% of the experts agreed with the questions posed on nutritional status, 60.0% with those on nutritional screening, 76.7% with those on nutritional therapy, and the entire panel of experts agreed with the questions posed on patient referral and multidisciplinary care. The experts agreed upon a high prevalence of malnutrition among cancer patients in Spain. Unlike medical and radiation oncologists, medical nutrition specialists believe that body composition assessment should not be carried out in all types of cancer patients during nutritional screening and that interventions can be conducted outside the oncology clinic. In general, it is recommended that nursing staff routinely perform nutritional screening before starting cancer treatment. It is necessary to develop a multidisciplinary action protocol that includes nutritional and/or sarcopenia screening. 相似文献
65.
66.
Sota Todoriki Yui Hosoda Tae Yamamoto Mayu Watanabe Akiyo Sekimoto Hiroshi Sato Takefumi Mori Mariko Miyazaki Nobuyuki Takahashi Emiko Sato 《Toxins》2022,14(4)
Uremic sarcopenia is a serious clinical problem associated with physical disability and increased morbidity and mortality. Methylglyoxal (MG) is a highly reactive, dicarbonyl uremic toxin that accumulates in the circulatory system in patients with chronic kidney disease (CKD) and is related to the pathology of uremic sarcopenia. The pathophysiology of uremic sarcopenia is multifactorial; however, the details remain unknown. We investigated the mechanisms of MG-induced muscle atrophy using mouse myoblast C2C12 cells, focusing on intracellular metabolism and mitochondrial injury. We found that one of the causative pathological mechanisms of uremic sarcopenia is metabolic flow change to fatty acid synthesis with MG-induced ATP shortage in myoblasts. Evaluation of cell viability revealed that MG showed toxic effects only in myoblast cells, but not in myotube cells. Expression of mRNA or protein analysis revealed that MG induces muscle atrophy, inflammation, fibrosis, and oxidative stress in myoblast cells. Target metabolomics revealed that MG induces metabolic alterations, such as a reduction in tricarboxylic acid cycle metabolites. In addition, MG induces mitochondrial morphological abnormalities in myoblasts. These changes resulted in the reduction of ATP derived from the mitochondria of myoblast cells. Our results indicate that MG is a pathogenic factor in sarcopenia in CKD. 相似文献
67.
肌少症是骨骼肌质量和力量逐渐下降的过程,是老年人面临的主要健康挑战。线粒体可通过改善生物合成、抗氧化防御、融合/分裂动力学以及线粒体自噬等,维持骨骼肌自身结构和功能的完整性,线粒体功能障碍是导致肌少症的重要因素之一。运动疗法可通过激活与调控线粒体生物合成和线粒体自噬,调节线粒体质量控制,延缓和防治肌少症发生和进展。 相似文献
68.
69.
70.